Analysts Set Cabot Corporation (NYSE:CBT) Price Target at $63.67

Cabot Corporation (NYSE:CBTGet Free Report) has been given an average rating of “Reduce” by the five research firms that are presently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $63.6667.

CBT has been the subject of a number of recent research reports. UBS Group reduced their price target on shares of Cabot from $82.00 to $65.00 and set a “neutral” rating for the company in a research report on Wednesday, November 5th. JPMorgan Chase & Co. reduced their target price on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a report on Friday, November 28th. Zacks Research lowered shares of Cabot from a “hold” rating to a “strong sell” rating in a report on Friday, November 7th. Mizuho cut their price target on Cabot from $78.00 to $72.00 and set an “outperform” rating on the stock in a research report on Monday, November 17th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a report on Wednesday, October 8th.

Get Our Latest Analysis on Cabot

Institutional Trading of Cabot

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. CIBC Bancorp USA Inc. purchased a new position in Cabot in the third quarter valued at $440,000. Danske Bank A S purchased a new position in shares of Cabot in the 3rd quarter valued at about $38,000. Caitong International Asset Management Co. Ltd raised its holdings in Cabot by 709.1% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 534 shares of the specialty chemicals company’s stock worth $41,000 after purchasing an additional 468 shares during the period. Advisory Services Network LLC purchased a new position in Cabot during the third quarter worth approximately $57,000. Finally, Morningstar Investment Management LLC acquired a new stake in Cabot in the third quarter valued at approximately $447,000. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Price Performance

NYSE CBT opened at $64.49 on Friday. The company has a market cap of $3.41 billion, a price-to-earnings ratio of 10.73, a PEG ratio of 3.42 and a beta of 0.90. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.61 and a quick ratio of 1.08. The stock’s fifty day moving average price is $66.58 and its 200 day moving average price is $73.46. Cabot has a 1 year low of $58.33 and a 1 year high of $108.93.

Cabot (NYSE:CBTGet Free Report) last posted its quarterly earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share for the quarter, missing the consensus estimate of $1.72 by ($0.02). Cabot had a net margin of 8.91% and a return on equity of 24.55%. The firm had revenue of $899.00 million for the quarter, compared to analysts’ expectations of $967.02 million. During the same quarter in the previous year, the firm posted $1.80 EPS. The firm’s revenue for the quarter was down 10.2% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. As a group, equities research analysts forecast that Cabot will post 7.57 earnings per share for the current year.

Cabot Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 12th. Stockholders of record on Friday, November 28th will be paid a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, November 28th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.8%. Cabot’s dividend payout ratio (DPR) is presently 29.95%.

Cabot Company Profile

(Get Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Featured Articles

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.